Comorbidity and Outcomes for Patients Over Age 65 Years Treated with Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndrome

被引：0
|
作者：
Conter, Henry J. [1 ]
Nhu-Nhu Nguyen [2 ]
Rondon, Gabriela [3 ]
Chen, Julianne [3 ]
Shpall, Elizabeth J. [3 ]
Khouri, Issa [3 ]
Giralt, Sergio A. [4 ]
Champlin, Richard E. [3 ]
DeLima, Marcos
机构：
[1] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USA
[2] Univ Texas Med Sch, Houston, TX USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA
[4] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.2032.2032
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2032
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Allogeneic stem cell transplantation for patients over age 65 with acute myelogenous leukemia and myelodysplastic syndrome.
    Conter, Henry Jacob
    Rondon, Gabriela
    Nhu-Nhu Nguyen
    Chen, Julianne
    Shpall, Elizabeth J.
    Khouri, Issa F.
    Giralt, Sergio
    Champlin, Richard E.
    De Lima, Marcos J. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [2] Platelet Recovery Before Allogeneic Stem Cell Transplantation Predicts Posttransplantation Outcomes in Patients with Acute Myelogenous Leukemia and Myelodysplastic Syndrome
    Alatrash, Gheath
    Pelosini, Matteo
    Saliba, Rima M.
    Koca, Ebru
    Rondon, Gabriela
    Andersson, Borje S.
    Chiattone, Alexandre
    Zhang, Weiqing
    Giralt, Sergio A.
    Cernosek, Amanda M.
    Kebriaei, Partow
    Alousi, Amin M.
    Popat, Uday R.
    Hosing, Chitra
    Khouri, Issa F.
    Champlin, Richard E.
    de Lima, Marcos J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (12) : 1841 - 1845
  • [3] Maintenance Therapy with Decitabine after Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndrome
    Pusic, Iskra
    Choi, Jaebok
    Fiala, Mark A.
    Gao, Feng
    Holt, Matthew
    Cashen, Amanda F.
    Vij, Ravi
    Abboud, Camille N.
    Stockerl-Goldstein, Keith E.
    Jacoby, Meghan A.
    Uy, Geoffrey L.
    Westervelt, Peter
    DiPersio, John F.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (10) : 1761 - 1769
  • [4] Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Patients with Treatment-Related Myelodysplastic Syndrome or Acute Myelogenous Leukemia
    Kobos, Rachel
    Steinherz, Peter G.
    Kernan, Nancy A.
    Prockop, Susan E.
    Scaradavou, Andromachi
    Small, Trudy N.
    Shukla, Neerav
    Khalaf, Ramzi
    O'Reilly, Richard J.
    Boulad, Farid
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (03) : 473 - 480
  • [5] Age up to 75 Years Does Not Influence the Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndrome
    Modi, Dipenkumar
    Deol, Abhinav
    Kim, Seongho
    Mellert, Kendra
    Ventimiglia, Marie
    Asif, Alavi
    Bhutani, Divaya
    Ayash, Lois
    Ratanatharathorn, Voravit
    Uberti, Joseph P.
    BLOOD, 2016, 128 (22)
  • [6] Effect of Age on Outcomes of Allogeneic Transplantation in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome
    Sigmund, Audrey M.
    Jiang, Justin
    Zhao, Qiuhong
    Elder, Patrick
    Rosko, Ashley E.
    Chaudhry, Maria
    Bumma, Naresh
    Khan, Abdullah
    Devarakonda, Srinivas
    Vasu, Sumithira
    Jaglowski, Samantha
    Mims, Alice S.
    Choe, Hannah
    Larkin, Karilyn
    Brammer, Jonathan E.
    Wall, Sarah A.
    Grieselhuber, Nicole
    Saad, Ayman
    Penza, Sam
    de Lima, Marcos J. G.
    Benson, Don M., Jr.
    Efebera, Yvonne A.
    Sharma, Nidhi
    BLOOD, 2021, 138
  • [7] Allogeneic transplantation for the elderly patient with acute myelogenous leukemia or myelodysplastic syndrome
    de Lima, M
    Giralt, S
    SEMINARS IN HEMATOLOGY, 2006, 43 (02) : 107 - 117
  • [8] Quality of Life following Allogeneic Stem Cell Transplantation for Patients Age >60 Years with Acute Myelogenous Leukemia
    Wright, Rachel
    Oremek, Maximilian
    Davies, David
    Kewley, Caitlin
    Singh, Alyssa
    Taitt, Nathaniel
    Kempshall, Emma
    Wilson, Keith
    Ingram, Wendy
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (08) : 1527 - 1533
  • [9] Charlson comorbidity index predicts outcomes of elderly after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome
    Chien, Sheng-Hsuan
    Yao, Ming
    Li, Chi-Cheng
    Chang, Ping-Ying
    Yu, Ming-Sun
    Huang, Cih-En
    Tan, Tran-Der
    Lin, Cheng-Hsien
    Yeh, Su-Peng
    Li, Sin-Syue
    Wang, Po-Nan
    Liu, Yi-Chang
    Gau, Jyh-Pyng
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2021, 120 (12) : 2144 - 2152
  • [10] Allogeneic hematopoietic stem cell transplantation in patients older than 65 years with acute myeloid leukemia and myelodysplastic syndrome: a 15-year experience
    Piemontese, Simona
    Lazzari, Lorenzo
    Ruggeri, Annalisa
    Marcatti, Magda
    Lupo Stanghellini, Maria Teresa
    Giglio, Fabio
    Greco, Raffaella
    Lorentino, Francesca
    Clerici, Daniela
    Assanelli, Andrea
    Farina, Francesca
    Mastaglio, Sara
    Xue, Elisabetta
    Marktel, Sarah
    Vago, Luca
    Gentner, Bernhard
    Secco, Chiara
    Corti, Consuelo
    Carrabba, Matteo Giovanni
    Bernardi, Massimo
    Peccatori, Jacopo
    Ciceri, Fabio
    BONE MARROW TRANSPLANTATION, 2022, 57 (04) : 678 - 680
12345